MedicaidCoverageMedium impact
[California] Carelon Medical Benefits Management updates
Anthem BCBS·CA · Genetics, Oncology, Pain Management +3 more·Provider Bulletin
Effective date
Oct 1, 2026
We identified it
Jun 25, 2026
Summary
Anthem Blue Cross (Medi-Cal Managed Care in California) is adopting updated Carelon Medical Benefits Management Clinical Appropriateness Guidelines effective October 1, 2026, covering six service categories: Genetic Testing, Chromosomal Microarray Analysis, Genetic Liquid Biopsy in Cancer Management, Pharmacogenetic Testing, Whole Exome/Genome Sequencing, and Musculoskeletal Interventional Pain Management. Existing prior authorization requirements remain unchanged, though new prior auth requirements may be announced separately before implementation.
Action Required
Before October 1, 2026: Billing team and clinical staff should access and review the updated Carelon guidelines (via the provided link) for the six affected service categories to understand revised clinical appropriateness criteria. No billing code changes are required at this time, but staff should monitor for a separate notice regarding any new prior authorization implementations. Update internal reference materials and clinical decision support tools to reflect the new guidelines. Continue current prior auth processes until notified of changes.